Evidence map›Paper›PMID 33396719›Full record

Observational studyNutrients2020

Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring.

Emilio J Laserna-Mendieta, María José Casanova, Ángel Arias, Laura Arias-González, Pedro Majano, Luis Alberto Mate, Carlos Humberto Gordillo-Vélez, Mirella Jiménez, Teresa Angueira, Emilia Tébar-Romero and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Dietary assessments in individuals living with coeliac disease: key considerations.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Review
  4. Global Approach to Follow-Up of Celiac Disease.Foods (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Emilio J Laserna-MendietaDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.ORCID 0000-0002-9039-7667
María José CasanovaDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, Spain.
Ángel AriasInstituto de Investigación Sanitaria Princesa, 28006 Madrid, Spain.ORCID 0000-0003-1006-0958
Laura Arias-GonzálezDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.
Pedro MajanoInstituto de Investigación Sanitaria Princesa, 28006 Madrid, Spain.
Luis Alberto MatePathology Department, Hospital General Mancha Centro, 13600 Alcázar de San Juan, Spain.
Carlos Humberto Gordillo-VélezInstituto de Investigación Sanitaria Princesa, 28006 Madrid, Spain.
Mirella JiménezDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, Spain.
Teresa AngueiraDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.
Emilia Tébar-RomeroDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.ORCID 0000-0002-1197-1289
María Jesús Carrillo-RamosDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.
María Ángeles Tejero-BustosDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.
Javier P GisbertDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, Spain.ORCID 0000-0003-2090-3445
Cecilio SantanderDepartment of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), 28006 Madrid, Spain.ORCID 0000-0001-5492-2535
Alfredo J LucendoDepartment of Gastroenterology, Hospital General de Tomelloso, 13700 Tomelloso, Spain.ORCID 0000-0003-1183-1072
Hospital General de Tomelloso · ESHospital Universitario de La Princesa · ES

Funding

Asociación Castellana de Aparato Digestivo Beca ACAD 2018
6 · The paper itself

Abstract

A lifelong gluten-free diet (GFD) is the only current treatment for celiac disease (CD), but strict compliance is complicated. Duodenal biopsies are the "gold standard" method for diagnosing CD, but they are not generally recommended for disease monitoring. We evaluated the sensitivity and specificity of fecal gluten immunogenic peptides (GIPs) to detect duodenal lesions in CD patients on a GFD and compared them with serum anti-tissue transglutaminase (tTG) IgA antibodies. A prospective study was conducted at two tertiary centers in Spain on a consecutive series of adolescents and adults with CD who maintained a long-lasting GFD. Adherence to a GFD and health-related quality of life were scored with validated questionnaires. Mucosal damage graded according to the Marsh-Oberhüber classification (Marsh 1/2/3) was used as the reference standard. Of the 97 patients included, 27 presented duodenal mucosal damage and 70 had normal biopsies (Marsh 0). The sensitivity (33%) and specificity (81%) of GIPs were similar to those provided by the two assays used to measure anti-tTG antibodies. Scores in questionnaires showed no association with GIP, but an association between GIPs and patients' self-reported gluten consumption was found (

Indexed as

FecesSurveys and QuestionnairesAdolescentAdultAntibodiesCeliac DiseaseDuodenumFemaleGlutensHumansIntestinal MucosaMaleMonitoring, PhysiologicPeptidesProspective StudiesAntibodiesGlutensPeptidesanti-tissue transglutaminase antibodiesceliac diseasediagnostic accuracygluten-free diet monitoringgluten immunogenic peptidesMarsh–Oberhüber type

Identifiers

PMID33396719
PMCPMC7824460
OpenAlexW3118151945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.